|
Asensio-López MC, Soler F, Sánchez-Más J, Pascual-Figal D, Fernández-Belda F, Lax A. Early oxidative damage induced by doxorubicin: Source of production, protection by GKT137831 and effect on Ca(2+) transporters in HL-1 cardiomyocytes. Arch Biochem Biophys. 2016 Mar 15;594:26-36. doi: 10.1016/j.abb.2016.02.021. Epub 2016 Feb 22. PubMed PMID: 26906075.
AÑO: 2016; IF: 3.165
|
26906075
|
Sánchez-Más J, Lax A, Asensio-López MC, Fernández-Del Palacio MJ, Caballero L, Navarro-Peñalver M, Pérez-Martínez MT, Gimeno-Blanes JR, Pascual-Figal DA. The TBX1 Transcription Factor in Cardiac Remodeling After Myocardial Infarction. Rev Esp Cardiol (Engl Ed). 2016 Nov;69(11):1042-1050. doi: 10.1016/j.rec.2016.04.033. Epub 2016 Jul 12. English, Spanish. PubMed PMID: 27422448.
AÑO: 2016; IF: 4.485
|
|
Lax A, Sanchez-Mas J, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor-Perez FJ, Januzzi JL, Pascual-Figal DA. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction. JACC Heart Fail. 2015 Jan;3(1):50-8. doi: 10.1016/j.jchf.2014.07.015. PubMed PMID: 25458175.
AÑO: 2015; IF: 7.218
|
|
Asensio-Lopez MC, Sanchez-Mas J, Pascual-Figal DA, de Torre C, Valdes M, Lax A. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes. Free Radic Biol Med. 2014 Feb;67:19-29. doi: 10.1016/j.freeradbiomed.2013.11.003. PubMed PMID: 24231192.
AÑO: 2014; IF: 5.736
|
|
Sanchez-Mas J, Lax A, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor F, Januzzi JL, Pascual-Figal DA. Galectin-3 expression in cardiac remodeling after myocardial infarction. Int J Cardiol. 2014;172(1):e98-e101. doi: 10.1016/j.ijcard.2013.12.129. PubMed PMID: 24433619.
AÑO: 2014; IF: 4.036
|